Concepedia

Publication | Open Access

Rabeprazole Can Overcome the Impact of CYP2C19 Polymorphism on Quadruple Therapy

DOIFull Paper Access

41

Citations

27

References

2010

Year

Chao‐Hung Kuo, Sophie S.W. Wang, Wen‐Hung Hsu, Fu‐Chen Kuo, Bi‐Chuang Weng, Chia‐Jung Li, Ping‐I Hsu, Angela Chen, Wen‐Chun Hung, Yuan‐Chieh Yang,
Helicobacter

Abstract

In quadruple therapy, rabeprazole-based regimens had better efficacy than esomeprazole-based regimens. CYP2C19 polymorphism also played an important role in quadruple therapy. It seems advisable to change PPI to rabeprazole in second-line quadruple therapy.

References

YearCitations

Page 1